SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-034284
Filing Date
2023-07-12
Accepted
2023-07-12 18:45:31
Documents
2
Period of Report
2023-05-26

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5510
2 EXHIBIT 24 brhc20055738_ex24.htm EX-24 5562
  Complete submission text file 0001140361-23-034284.txt   12450
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACLARIS THERAPEUTICS, INC. 101 LINDENWOOD DRIVE, SUITE 400 MALVERN PA 19355
Business Address
Ali-Jackson Kamil (Reporting) CIK: 0001654337 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 231085472